⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Boric Acid SCHEMBL2348129 | 1.00 | LMNA (0.80) | — | |
| Boric Acid SCHEMBL6849825 | 1.00 | LMNA (0.80) | — | |
| Boric Acid SCHEMBL11056227 | 1.00 | LMNA (0.80) | — | |
| Boric Acid SCHEMBL4096848 | 1.00 | — | — | |
| Boric Acid SCHEMBL11452757 | 1.00 | LMNA (0.80) | — | |
| Boric Acid SCHEMBL1228340 | 1.00 | — | — | |
| Boric Acid SCHEMBL1228341 | 1.00 | LMNA (0.80) | — | |
| Boric Acid SCHEMBL15874 | 1.00 | LMNA (0.80) | — | |
| Boric Acid SCHEMBL1229852 | 1.00 | LMNA (0.80) | — | |
| Boric Acid SCHEMBL379131 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250197845-A1 | COMPOSITIONS AND METHODS FOR IMPROVED DNA-ENCODED LIBRARY PREPARATION | THE ROCKEFELLER UNIVERSITY | 2025-06-19 | — | — | US | disclosed |
| WO-2025018373-A1 | METHYLENEBISBIPHENYL COMPOUND AND USE THEREOF | 住友化学株式会社 | 2025-01-23 | — | — | WO | disclosed |
| WO-2025018374-A1 | ACRYLIC ACID DERIVATIVE AND USE THEREOF | 住友化学株式会社 | 2025-01-23 | — | — | WO | disclosed |
| WO-2023183796-A2 | COMPOSITIONS AND METHODS FOR IMPROVED DNA-ENCODED LIBRARY PREPARATION | THE ROCKEFELLER UNIVERSITY (US) | 2023-09-28 | — | — | WO | disclosed |
| CN-105764920-A | Modified bacterial collagen-like proteins | 联邦科学工业研究组织 | 2016-07-13 | — | — | CN | disclosed |
| CN-102614535-B | Medical contrast agent and method for producing micelle containing fluorescent gold nanocluster | UNIV CHUNG YUAN CHRISTIAN | 2013-07-31 | — | — | CN | disclosed |
| CN-102614535-A | Medical contrast agent and method for producing micelle containing fluorescent gold nanocluster | UNIV CHUNG YUAN CHRISTIAN | 2012-08-01 | — | — | CN | disclosed |
| CN-101990437-A | Stable aqueous cyclosporin compositions | ALCON PHARMACEUTICALS LTD | 2011-03-23 | — | — | CN | disclosed |
| CN-101087607-B | Ophthalmic compositions and methods of using the same | BAUSCH & LOMB | 2010-07-28 | — | — | CN | disclosed |
| CN-101677949-A | Stable ophthalmical composition comprising ketotifen and naphazoline and methods of making same | BAUSCH & LOMB | 2010-03-24 | — | — | CN | disclosed |
| WO-1998013464-A1 | DETERGENT COMPOSITION COMPRISING CATIONIC AMINES AND CELLULASE ENZYMES | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-02 | — | — | WO | disclosed |
| WO-1998013448-A1 | DETERGENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-02 | — | — | WO | disclosed |
| WO-1998013449-A1 | DETERGENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-02 | — | — | WO | disclosed |
| WO-1998013451-A1 | DETERGENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-02 | — | — | WO | disclosed |
| WO-1997044417-A1 | DETERGENT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1997-11-27 | — | — | WO | disclosed |
| US-4710513-A | Substituted pyranone inhibitors of cholesterol synthesis | MERCK & CO., INC. (US) | 1987-12-01 | — | — | US | disclosed |
| US-4567289-A | ANTICHOLESTEROL ANTILIPEMIC | MERCK & CO., INC. (US) | 1986-01-28 | — | — | US | disclosed |
| US-4459422-A | Substituted pyranone inhibitors of cholesterol synthesis | MERCK & CO., INC. (US) | 1984-07-10 | — | — | US | disclosed |
| US-4375475-A | ANTICHOLESTEROL AGENTS | MERCK & CO., INC. (US) | 1983-03-01 | — | — | US | disclosed |
| EP-0024348-A1 | Substituted 6-Phenethyl-and phenylethenyl-3,4,5,6-tetrahydro-4-hydroxytetraydropyran-2-ones in the4-R trans stereoisomeric forms and the corresponding dihydroxy acids, process for preparing and pharmaceutical composition comprising them | MERCK & CO. INC. (US) | 1981-03-04 | — | — | EP | disclosed |